| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Merus N.V.
13D/A
Amendment 1
MRUS · N5749R100
|
0% |
12/30/2025
Event 12/30/2025
|
|||
| Genmab A/S | 0% | ||||
| Genmab Holding II B.V. | 0% | ||||
|
Merus N.V.
13D
MRUS · N5749R100
|
94.8% |
12/19/2025
Event 12/12/2025
|
|||
| Genmab A/S | 94.8% | ||||
| Genmab Holding II B.V. | 94.8% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.